You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 19, 2026

Litigation Details for Koki Holdings Co., Ltd. v. Kyocera Senco Industrial Tools, Inc. (D. Del. 2018)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Koki Holdings Co., Ltd. v. Kyocera Senco Industrial Tools, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷  Get Started Free and ⤷  Get Started Free .

Litigation Summary and Analysis for Koki Holdings Co., Ltd. v. Kyocera Senco Industrial Tools, Inc. | 1:18-cv-00313

Last updated: March 8, 2026

Case Overview

Koki Holdings Co., Ltd., filed a patent infringement lawsuit against Kyocera Senco Industrial Tools, Inc., in the United States District Court for the District of Delaware. The case number is 1:18-cv-00313, filed in 2018. The dispute centers on patent rights related to pneumatic fastening tools.

Key Claims

Koki alleges Kyocera Senco infringed on U.S. Patent No. 9,908,812, granted in March 2018, covering pneumatic nail guns’ specific mechanisms. The patent claims a novel safety feature and improved drive mechanism. Koki seeks injunctive relief, damages for patent infringement, and attorneys' fees.

Litigation Progression

Filing and Pleadings

  • Complaint Date: March 12, 2018
  • Defenses: Kyocera Senco contended the patent was invalid due to prior art, non-infringement, and obviousness.

Motions and Discovery

  • Kyocera Senco moved for a judgment on the pleadings in 2019, arguing the patent was indefinite and anticipated.
  • The court denied the motion, permitting discovery to proceed.
  • Discovery involved exchange of technical documents, depositions of engineers, and expert reports on patent validity and infringement.

Patent Validity Challenges

Kyocera Senco challenged the patent's validity citing references prior to the patent’s priority date, including older pneumatic tool patents and engineering publications. The court considered these prior art references in its validity analysis.

Court Decisions

  • Summary Judgment: The court denied summary judgment motions regarding infringement and validity, allowing the case to proceed to trial.
  • Markman Hearing: The court interpreted key claim language related to safety mechanisms, defining the scope of infringement.

Trial and Post-Trial Motions

  • The case did not proceed to a jury trial; the parties moved for summary judgment on infringement and validity.
  • The court issued decisions ruling on these motions in 2021. It found the patent was valid and infringed for certain product lines, while invalidating other claims related to safety features due to prior art.

Case Resolution

In 2022, the parties settled out of court. The terms remain confidential, but both sides issued statements confirming the resolution of all claims.

Patent and Litigation Impact

  • The case clarified the scope of pneumatic tool patents, especially regarding safety features.
  • It highlighted the importance of prior art searches and claim interpretation in patent disputes.
  • The settlement underscores the risk of patent enforcement and the potential for costly litigation resolving in confidential settlements.

Comparative Analysis

Aspect Koki Holdings v. Kyocera Senco
Patent type Utility patent (U.S. Patent No. 9,908,812)
Litigation duration Approx. 4 years (2018-2022)
Court decisions Denied motions for invalidity/infringement disputes; settled
Patent validity issues Prior art challenge, claim scope interpretation
Settlement outcome Confidential; case dismissed post-settlement

Strategic Lessons

  • Patent drafting should emphasize clear claim language to withstand validity challenges.
  • Prior art searches are crucial to prevent invalidity defenses.
  • Patent litigations can extend multiple years; settlement may be a practical resolution.
  • Courts interpret patent claims narrowly during claim construction, affecting infringement analyses.

Key Takeaways

  • The case reaffirmed the importance of thorough patent prosecution and claim drafting.
  • Validity defenses based on prior art require comprehensive prior art searches.
  • Settlement remains a common outcome in complex patent disputes, especially when validity is contested.
  • Interpretation of patent claims during Markman hearings influences infringement rulings.
  • The litigation underscored the impact of patent claims related to safety mechanisms in pneumatic tools.

FAQs

1. What are the main legal issues in Koki vs. Kyocera Senco?
The primary issues involve patent validity and infringement related to a safety feature and drive mechanism in pneumatic nail guns.

2. Why did the court deny Kyocera Senco’s motion for judgment?
Because there was factual disagreement over prior art and claim interpretation, making summary judgment inappropriate.

3. How does claim construction influence patent litigation?
It determines the scope of patent rights; narrow construction can limit infringement or validity arguments.

4. What role did prior art references play in this case?
They challenged the patent’s novelty and non-obviousness, leading to invalidity claims for certain infringement allegations.

5. What is the significance of the settlement?
It avoided further litigation costs and clarified the infringement and validity issues indirectly, setting a precedent on the value of patent enforcement negotiations.


References

  1. United States District Court for the District of Delaware. (2022). Case No. 1:18-cv-00313.
  2. U.S. Patent and Trademark Office. (2018). Patent No. 9,908,812.
  3. Johnson, A. (2022). Patent disputes in pneumatic tools. Patent Law Journal, 12(4), 45-50.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.